BCM
VIVS

Bayesian Capital Management’s VivoSim Labs VIVS Stock Holding History

Bayesian Capital Management’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-47
Closed -$42K – 535
2016
Q2 		$42K Buy
+47
New +$31.5K 0.03% 380

Other funds holding VIVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bayesian Capital Management's VIVS Position: Q3 2016 in Review

Bayesian Capital Management sold out of VivoSim Labs (VIVS) in Q3 2016, closing a stake of 47 shares — an estimated $42K sold.

Bayesian Capital Management first reported a position in VIVS in Q2 2016 and held it in 1 quarter. The position peaked at $42K in Q2 2016. 122 funds tracked by Wall St. Rank hold VIVS as of Q3 2016.

  • Bayesian Capital Management reported no remaining VivoSim Labs position as of Q3 2016 after selling out during the quarter.
  • Bayesian Capital Management sold 47 VivoSim Labs shares in Q3 2016, an estimated $42K.
  • Bayesian Capital Management first reported a position in VivoSim Labs in Q2 2016 and held it in 1 quarter.
  • Bayesian Capital Management's VivoSim Labs position peaked at $42K in Q2 2016.
  • 122 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2016.

Based on Bayesian Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.